Viral Antigens Market Forecast, Trend, Analysis & Competition Tracking - Global Market Insights 2020 to 2025

Published on : Jun-2020 | List of Tables : 41 | List of Figures : 118 | No. of Pages : 170 | Report Code : FACT1305MR |

Viral Antigens Market Insights: Advancement in Image Analysis and Improvised Informatics Solutions to Boost Growth

Adoption of viral antigens in vaccine development by clinicians and researchers has been increasing on a significant pace. Advancements in image analysis software and informatics platforms for viral antigen detection are driving the vaccine development research, which is expected to fuel the viral antigens market growth over the forecast period (2020-2025). Most of the recently developed techniques such as Electron Microscopy workflow are promising for advancement in viral research. For example, with development in image systems, it is possible to capture image in real time and produce immunoassay results which are efficient and reproducible. Frequent outbreaks of infectious diseases caused by viruses, such as influenza, hepatitis, AIDS, and recently COVID-19, are creating urgency in the vaccine research and development. The result is expected to lead to rapid growth of the viral antigens market.

The usage of viral antigens will be further driven by development of multiple imaging modes. With rapid advancement in both science and technology, it has become possible to capture both picture and videos of viral antigens immunogenicity analysis in HD mode. Advanced automated tools have also been developed that capture high quality HD images in different phases and present reproducible images both in red and green fluorescent contrasting forms, for differential cell analysis. Using, differential objectives on an automated turret, the devices can be used to address a variety of parallel applications.

Viral Antigens Market Analysis by Technique: ELISA Remains Highly Preferred

ELISAs are widely used as an effective tool in the detection and diagnosis of virus infection. These immunoassays are garnering momentum as safe, specific, and rapid, owing to the ability to produce recombinant viral proteins. Adoption of ELISA for identifying viral antigens is expected to account for major share of the stakeholders’ bottom lines and increase at a significant CAGR of 8.2% during the forecast period.

Electron microscopy is rapid emerging as a powerful technique to identify viral antigens and determine their structural organization and localization within viruses and vaccines. With greater awareness of electron microscopy among professionals in vaccine research, market stakeholders are directing their focus to this category. Adoption of electron microscopy is projected at a solid 9.4% CAGR through 2025.

viral antigens market growth forecast by technique type

For more comprehensive insights on the viral antigens market segmentation, request a report sample

Regional Analysis: North America to Account for Major Share of Viral Antigens Market Value

North America is expected to hold approximately 48% of the global viral antigens market value during the forecast period. In the U.S., key players are channelizing efforts to increase flexibility, productivity and throughput capabilities and redefine control productivity. Favorable government policies for vaccine development and significant advancements in biomedical research infrastructure are contributing to growth of the North America’s viral antigens market.

Europe is expected to hold second largest share in the viral antigens market, attributing to increased funding for clinical research in all life science disciplines.  With greater availability of resources and workforce, market players are eyeing opportunities in East Asia which is expected to show a significant growth rate in the coming years.

viral antigens market growth value forecast by region

To get in-depth insights on the regional growth prospects of the viral antigens market, ask an expert analyst.

Viral Antigens Market: Competition Analysis

Technological advancements in biopharmaceutical industry are offering significant growth opportunities for players in the viral antigens market, leading to the launch of new and advanced products. Moreover, increase in the product development and new launches, including the launch of several novel recombinant antigens for the development of antibody tests for COVID-19 will further accelerate the expansion of the viral antigens market. For instance, in 2020, Creative Diagnostics launched new immunoassay kits for direct detection of the new coronavirus and antibodies against SARS-CoV-2. Later, The Native Antigen Company and OXGENE signed a mutual agreement to increase production of COVID-19 antigens for manufacturing diagnostic kits and vaccine development and supporting more researchers in their critical work.

COVID-19 Impact Analysis

Increasing demand for viral antigens in COVID-19 vaccine development and diagnostic kits is expected to propel growth of the global viral antigens market. According to the WHO, currently there are more than 2 million active coronavirus cases worldwide, which are initiating the adoption of viral recombinant antigens that are capable of producing recombinant viral proteins. Increasing cases of coronavirus have significantly led to a spike in demand for COVID-19 antibody detection kits focused towards prevention, early detection and monitoring of the disease. Moreover, growing incidence of acute diseases such as cancers, AIDS, hepatitis & infectious diseases is influencing the use of the high competency of viral antigens to reduce the risk of such diseases.

Analysts’ Viewpoint

“The advent of technologically advanced vaccine research platforms and increase R&D activities in viral proteins remain major growth drivers of the viral antigens market. Significant efforts to develop rapid diagnostic kits and vaccines for the novel coronavirus will also uplift growth prospects of the market”.

Viral Antigens Market: Report Scope

The recent study on viral antigens market by Fact.MR incorporates a five-year forecast period from 2020 to 2025 and explicates on vital dynamics such as the key drivers, opportunities and restraints impacting the market growth. The report provides an in-depth study concerning the revenue, market share and year-on-year growth across the following segments: component type, technique, and end user.

In addition, a regional landscape incorporating the above mentioned segments has been embedded within the report. Regional analysis is done based on the following geographies: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. In the final section, a competitive landscape providing information on the prominent market players, their revenue, market share, collaborations and product launches has been included.

Viral Antigens Market–Report Scope

Fact.MR recently published a market study on the global market for viral antigens. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities,and restraints, as well as detailed information about the viral antigens market structure. The market study presents exclusive information about how the viral antigens market will grow during the forecast period of 2020-2030.

Key indicators of market growth, which include year-on-year (Y-o-Y) growth of the market and compounded annual growth rate (CAGR), are explained in Fact.MR’s study in a comprehensive manner. This information can help readers understand the quantitative growth prospects of the viral antigens market during the forecast period.

The study is relevant for stakeholders in the viral antigens market, including, manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Stakeholders in the viral antigens market, investors, industry experts, researchers, and journalists, as well as business researchers can leverage the information and data presented in Fact.MR’s study.

It also offers actionable insights based on the future trends in the viral antigens market. Furthermore, small businesses and new entrants in the viral antigens market can make use of the information presented in this study, based on which, they can make appropriate business decisions to gain momentum in the market.

Key Segments of Viral Antigens Market

Fact.MR’s study on the viral antigens market offers information divided into three important segments—component, technique,end user and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Component

Technique

End User

Region

  • Influenza Viral Antigens
  • Coronavirus Antigens
  • Zika Virus Antigens
  • Ebola Virus Antigens
  • Dengue Virus Antigens
  • Herpes Simplex Virus (HSV) Viral Antigens
  • Rotavirus Viral Antigens
  • Epstein-Barr Virus Antigens
  • Hepatitis A-E Virus Antigens
  • Parainfluenza Virus Antigens
  • Measles Virus Antigens
  • Adenovirus Viral Antigens
  • Mumps/Parotitis Virus Antigens
  • Varicella Zoster Virus (VZV) Antigens
  • Others

 

  • ELISA
  • Immunoassay
  • Hemagglutination
  • Radioimmunoassay (RIA)
  • Immunoperoxidase Staining
  • Immunofluorescence
  • Electron Microscopy
  • Others
  • Hospitals
  • Clinics
  • Laboratories
  • Diagnostic Centers
  • Blood Banks
  • Research Institutes
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Key Questions Answered in Fact.MR’s Viral Antigens Market Report

  • Which regions will continue to remain the most profitable markets for viral antigens market players?
  • Which factors will induce a change in demand for viral antigens during the assessment period?
  • How will changing trends impact the viral antigens market?
  • How can market players capture the low-hanging opportunities in the viral antigens market in developed regions?
  • Which companies are leading the viral antigens market?
  • What are the winning strategies of stakeholders in the viral antigens market to upscale their position in this landscape?

Viral Antigens Market: Research Methodology

In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the viral antigens market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of conclusions.

Secondary resources referred to analysts during the production of the viral antigens market study include statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary resources and secondary resources acts as a validation from companies in the viral antigens market, and makes Fact.MR’s projection on the growth prospects of the viral antigens market more accurate and reliable.

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Market Background

    4.1. Macro-Economic Factors

        4.1.1. GDP Growth Outlook

        4.1.2. Global Healthcare Industry Outlook

        4.1.3. Increasing per capita Healthcare Spending

        4.1.4. Income Per Capita Outlook

    4.2. Forecast Factors - Relevance & Impact

        4.2.1. Increase in R&D Funding and Grants 

        4.2.2. Increase in Number of Viral Diseases

        4.2.3. Diagnosis Seeking Rate

        4.2.4. Industry Consolidation to Increase Capacity

        4.2.5. Increase in Manufacturing Activity

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity Analysis

5. Market Context

    5.1. Key Product Features and their USPs

    5.2. Technology Adoption / Usage Analysis

    5.3. Major Application in Viral Disease Diagnosis

    5.4. Key Promotional Strategies, By Manufacturers

    5.5. Regulations, By Region

6. COVID19 Crisis Analysis

    6.1. Current COVID19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as compared to 2008 financial analysis

    6.4. COVID19 and Impact Analysis

        6.4.1. Revenue By Product

        6.4.2. Revenue By Technique

        6.4.3. Revenue By End User

        6.4.4. Revenue By Country

    6.5. 2020 Market Scenario

    6.6. Quarter by Quarter Forecast

    6.7. Projected recovery Quarter

    6.8. Recovery Scenario – Short term, Midterm and Long Term Impact

7. Global Viral Antigens Market - Pricing Analysis

    7.1. Country Pricing Analysis By Component

    7.2. Pricing Break-up

        7.2.1. Manufacturer Level Pricing

        7.2.2. Distributor Level Pricing

    7.3. Latin America and Middle East Average Pricing Analysis Benchmark

8. Global Viral Antigens Market Value Analysis 2015 – 2019 and Forecast, 2020 – 2030

    8.1. Historical Market Value (US$ Mn) Analysis, 2015 – 2019

    8.2. Current and Future Market Value (US$ Mn) Projections, 2020 – 2030

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

9. Global Viral Antigens Market Analysis 2015 – 2019 and Forecast 2020 – 2030, by Component 

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Component, 2015 – 2019

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Component, 2020 – 2030

        9.3.1. Influenza Viral Antigens

        9.3.2. Coronavirus Antigens

        9.3.3. Zika Virus Antigens

        9.3.4. Ebola Virus Antigens

        9.3.5. Dengue Virus Antigens

        9.3.6. Herpes Simplex Virus (HSV) Viral Antigens

        9.3.7. Rotavirus Viral Antigens

        9.3.8. Epstein-Barr Virus Antigens

        9.3.9. Hepatitis A-E Virus Antigens

        9.3.10. Parainfluenza Virus Antigens

        9.3.11. Measles Virus Antigens

        9.3.12. Adenovirus Type 2 Hexon Viral Antigens

        9.3.13. Mumps/Parotitis Virus Antigens

        9.3.14. Varicella Zoster Virus (VZV) Antigens

        9.3.15. Others

    9.4. Market Attractiveness Analysis By Component

10. Global Viral Antigens Market Analysis 2015 – 2019 and Forecast 2020 – 2030, by Technique 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Technique, 2015 – 2019

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technique, 2020 – 2030

        10.3.1. ELISA

        10.3.2. Immunoassay

        10.3.3. Hemagglutination

        10.3.4. Radioimmunoassay (RIA)

        10.3.5. Immunoperoxidase Staining

        10.3.6. Immunofluorescence

        10.3.7. Electron Microscopy

        10.3.8. Others 

    10.4. Market Attractiveness Analysis By Technique

11. Global Viral Antigens Market Analysis 2015 – 2019 and Forecast 2020 – 2030, By End User 

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By End User, 2015 – 2019

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020 – 2030

        11.3.1. Hospitals

        11.3.2. Clinics

        11.3.3. Laboratories

        11.3.4. Diagnostic Centers

        11.3.5. Blood Banks

        11.3.6. Research Institutes 

    11.4. Market Attractiveness Analysis By End User

12. Global Viral Antigens Market Analysis 2015 – 2019 and Forecast 2020 – 2030, by Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 – 2019

    12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 – 2030

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. East Asia

        12.3.5. South Asia

        12.3.6. Oceania

        12.3.7. Middle East and Africa (MEA)

    12.4. Market Attractiveness Analysis By Region

13. North America Viral Antigens Market Analysis 2015 – 2019 and Forecast 2020 – 2030

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 – 2030

        13.3.1.  By Country

            13.3.1.1. U.S.

            13.3.1.2. Canada

        13.3.2. By Component

        13.3.3. By Technique

        13.3.4. By End User

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Latin America Viral Antigens Market Analysis 2015 – 2019 and Forecast 2020 – 2030

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 – 2030

        14.3.1.  By Country

            14.3.1.1. Brazil

            14.3.1.2. Mexico

            14.3.1.3. Argentina

            14.3.1.4. Rest of Latin America

        14.3.2. By Component

        14.3.3. By Technique

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Europe Viral Antigens Market Analysis 2015 – 2019 and Forecast 2020 – 2030

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 – 2030

        15.3.1.  By Country

            15.3.1.1. Germany

            15.3.1.2. Italy

            15.3.1.3. France

            15.3.1.4. U.K.

            15.3.1.5. Spain

            15.3.1.6. Russia

            15.3.1.7. Rest of Europe

        15.3.2. By Component

        15.3.3. By Technique

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. South Asia Viral Antigens Market Analysis 2015 – 2019 and Forecast 2020 – 2030

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 – 2030

        16.3.1.  By Country

            16.3.1.1. India

            16.3.1.2. Thailand

            16.3.1.3. Indonesia

            16.3.1.4. Malaysia

            16.3.1.5. Rest of South Asia

        16.3.2. By Component

        16.3.3. By Technique

        16.3.4. By End User

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. East Asia Viral Antigens Market Analysis 2015 – 2019 and Forecast 2020 – 2030

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 – 2030

        17.3.1.  By Country

            17.3.1.1. China

            17.3.1.2. Japan

            17.3.1.3. South Korea

            17.3.1.4. Rest of East Asia

        17.3.2. By Component

        17.3.3. By Technique

        17.3.4. By End User

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. Oceania Viral Antigens Market Analysis 2015 – 2019 and Forecast 2020 – 2030

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

    18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 – 2030

        18.3.1.  By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Component

        18.3.3. By Technique

        18.3.4. By End User

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Viral Antigens Market Analysis 2015 – 2019 and Forecast 2020 – 2030

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

    19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 – 2030

        19.3.1.  By Country

            19.3.1.1. GCC Countries

            19.3.1.2. South Africa

            19.3.1.3. Rest of Middle East and Africa

        19.3.2. By Component

        19.3.3. By Technique

        19.3.4. By End User

    19.4. Market Attractiveness Analysis

    19.5. Drivers and Restraints - Impact Analysis

20. Key and Emerging Countries Viral Antigens Market Analysis 2015 – 2019 and Forecast 2020 – 2030

    20.1. Introduction

        20.1.1. Market Value Proportion Analysis, By Key Countries

        20.1.2. Global Vs. Country Growth Comparison

    20.2. U.S. Viral Antigens Market Analysis

        20.2.1. By Component

        20.2.2. By Technique

        20.2.3. By End User

    20.3. Canada Viral Antigens Market Analysis

        20.3.1. By Component

        20.3.2. By Technique

        20.3.3. By End User

    20.4. Mexico Viral Antigens Market Analysis

        20.4.1. By Component

        20.4.2. By Technique

        20.4.3. By End User

    20.5. Brazil Viral Antigens Market Analysis

        20.5.1. By Component 

        20.5.2. By Technique

        20.5.3. By End User

    20.6. U.K. Viral Antigens Market Analysis

        20.6.1. By Component

        20.6.2. By Technique

        20.6.3. By End User

    20.7. Germany Viral Antigens Market Analysis

        20.7.1. By Component

        20.7.2. By Technique

        20.7.3. By End User

    20.8. France Viral Antigens Market Analysis

        20.8.1. By Component

        20.8.2. By Technique

        20.8.3. By End User

    20.9. Italy Viral Antigens Market Analysis

        20.9.1. By Component

        20.9.2. By Technique

        20.9.3. By End User

    20.10. Spain Viral Antigens Market Analysis

        20.10.1. By Component

        20.10.2. By Technique

        20.10.3. By End User

    20.11. BENELUX Viral Antigens Market Analysis

        20.11.1. By Component

        20.11.2. By Technique

        20.11.3. By End User

    20.12. Russia Viral Antigens Market Analysis

        20.12.1. By Component

        20.12.2. By Technique

        20.12.3. By End User

    20.13. China Viral Antigens Market Analysis

        20.13.1. By Component

        20.13.2. By Technique

        20.13.3. By End User

    20.14. Japan Viral Antigens Market Analysis

        20.14.1. By Component

        20.14.2. By Technique

        20.14.3. By End User

    20.15. South Korea Viral Antigens Market Analysis

        20.15.1. By Component

        20.15.2. By Technique

        20.15.3. By End User

    20.16. India Viral Antigens Market Analysis

        20.16.1. By Component

        20.16.2. By Technique

        20.16.3. By End User

    20.17. ASEAN Viral Antigens Market Analysis

        20.17.1. By Component

        20.17.2. By Technique

        20.17.3. By End User

    20.18. Australia Viral Antigens Market Analysis

        20.18.1. By Component

        20.18.2. By Technique

        20.18.3. By End User

    20.19. New Zealand Viral Antigens Market Analysis

        20.19.1. By Component

        20.19.2. By Technique

        20.19.3. By End User

    20.20. GCC Countries Viral Antigens Market Analysis

        20.20.1. By Component

        20.20.2. By Technique

        20.20.3. By End User

    20.21. Turkey Viral Antigens Market Analysis

        20.21.1. By Component

        20.21.2. By Technique

        20.21.3. By End User

    20.22. South Africa Viral Antigens Market Analysis

        20.22.1. By Component

        20.22.2. By Technique

        20.22.3. By End User

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies

    21.2. Market Concentration

    21.3. Market Share Analysis of Top Players

    21.4. Market Presence Analysis

        21.4.1. By Regional footprint of Players

        21.4.2. Product foot print by Players

        21.4.3. Channel Foot Print by Players

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive 

        22.3.1. Microbix Biosystems Inc.

            22.3.1.1. Overview

            22.3.1.2. Product Portfolio

            22.3.1.3. Analyst Commentary 

            22.3.1.4. Key Financials

            22.3.1.5. Recent Developments

            22.3.1.6. Sales Footprint

            22.3.1.7. Strategy Overview

                22.3.1.7.1. Marketing Strategy

                22.3.1.7.2. Product Strategy

                22.3.1.7.3. Channel Strategy

        22.3.2. The Native Antigen Company

            22.3.2.1. Overview

            22.3.2.2. Product Portfolio

            22.3.2.3. Analyst Commentary 

            22.3.2.4. Key Financials

            22.3.2.5. Recent Developments

            22.3.2.6. Sales Footprint

            22.3.2.7. Strategy Overview

                22.3.2.7.1. Marketing Strategy

                22.3.2.7.2. Product Strategy

                22.3.2.7.3. Channel Strategy

        22.3.3. Creative Diagnostics

            22.3.3.1. Overview

            22.3.3.2. Product Portfolio

            22.3.3.3. Analyst Commentary 

            22.3.3.4. Key Financials

            22.3.3.5. Recent Developments

            22.3.3.6. Sales Footprint

            22.3.3.7. Strategy Overview

                22.3.3.7.1. Marketing Strategy

                22.3.3.7.2. Product Strategy

                22.3.3.7.3. Channel Strategy

        22.3.4. Bio Rad Laboratories

            22.3.4.1. Overview

            22.3.4.2. Product Portfolio

            22.3.4.3. Analyst Commentary 

            22.3.4.4. Key Financials

            22.3.4.5. Recent Developments

            22.3.4.6. Sales Footprint

            22.3.4.7. Strategy Overview

                22.3.4.7.1. Marketing Strategy

                22.3.4.7.2. Product Strategy

                22.3.4.7.3. Channel Strategy

        22.3.5. Novartis Diagnostics

            22.3.5.1. Overview

            22.3.5.2. Product Portfolio

            22.3.5.3. Analyst Commentary 

            22.3.5.4. Key Financials

            22.3.5.5. Recent Developments

            22.3.5.6. Sales Footprint

            22.3.5.7. Strategy Overview

                22.3.5.7.1. Marketing Strategy

                22.3.5.7.2. Product Strategy

                22.3.5.7.3. Channel Strategy

        22.3.6. Aalto Bio Reagents

            22.3.6.1. Overview

            22.3.6.2. Product Portfolio

            22.3.6.3. Analyst Commentary 

            22.3.6.4. Key Financials

            22.3.6.5. Recent Developments

            22.3.6.6. Sales Footprint

            22.3.6.7. Strategy Overview

                22.3.6.7.1. Marketing Strategy

                22.3.6.7.2. Product Strategy

                22.3.6.7.3. Channel Strategy

        22.3.7. Advanced Biotechnologies Inc.

            22.3.7.1. Overview

            22.3.7.2. Product Portfolio

            22.3.7.3. Analyst Commentary 

            22.3.7.4. Key Financials

            22.3.7.5. Recent Developments

            22.3.7.6. Sales Footprint

            22.3.7.7. Strategy Overview

                22.3.7.7.1. Marketing Strategy

                22.3.7.7.2. Product Strategy

                22.3.7.7.3. Channel Strategy

        22.3.8. Viral Antigens, Inc.

            22.3.8.1. Overview

            22.3.8.2. Product Portfolio

            22.3.8.3. Analyst Commentary 

            22.3.8.4. Key Financials

            22.3.8.5. Recent Developments

            22.3.8.6. Sales Footprint

            22.3.8.7. Strategy Overview

                22.3.8.7.1. Marketing Strategy

                22.3.8.7.2. Product Strategy

                22.3.8.7.3. Channel Strategy

        22.3.9. ProSpec-Tany TechnoGene Ltd.

            22.3.9.1. Overview

            22.3.9.2. Product Portfolio

            22.3.9.3. Analyst Commentary 

            22.3.9.4. Key Financials

            22.3.9.5. Recent Developments

            22.3.9.6. Sales Footprint

            22.3.9.7. Strategy Overview

                22.3.9.7.1. Marketing Strategy

                22.3.9.7.2. Product Strategy

                22.3.9.7.3. Channel Strategy

        22.3.10. ACROBiosystems Inc. 

            22.3.10.1. Overview

            22.3.10.2. Product Portfolio

            22.3.10.3. Analyst Commentary 

            22.3.10.4. Key Financials

            22.3.10.5. Recent Developments

            22.3.10.6. Sales Footprint

            22.3.10.7. Strategy Overview

                22.3.10.7.1. Marketing Strategy

                22.3.10.7.2. Product Strategy

                22.3.10.7.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Our Clients

Viral Antigens Market Forecast, Trend, Analysis & Competition Tracking - Global Market Insights 2020 to 2025